世界各国のリアルタイムなデータ・インテリジェンスで皆様をお手伝い



北米の止血剤・組織シーラント市場予測 2019-2027年

NORTH AMERICA HEMOSTATS AND TISSUE SEALANTS MARKET FORECAST 2019-2027

 

出版社 出版日電子媒体価格ページ数
Inkwood Research
インクウッドリサーチ
2018年12月 US$ 1,250
シングルユーザライセンス(印刷不可PDF)
89p

※当ページの内容はウェブ更新時の情報です。
最新版の価格やページ数などの情報についてはお問合せください。

サマリー

この調査レポートは北米の止血剤・組織シーラント市場を分析・予測したInkwood Researchの市場調査報告書です。

Overview

KEY FINDINGS
The hemostasis and tissue sealing agents market in North American is expected to grow at a CAGR of 7.36% over the forecast period 2019-2027. The North American regional market was valued at $ xx million in 2018 and is estimated to extent up to $ xx million by 2027. This regional market at the North America holds the largest share of the hemostats and tissue sealants products due to the aggressive marketing of such devices.

MARKET INSIGHTS

The United States and Canada are considered for this market study. The US has the largest share for the said market in this region. This can be reasoned to the increasing obese & geriatric population that makes up the vast consumer market in the North America. Also, the interest of market players is growing in the underpenetrated sectors that can utilize hemostasis and tissue sealing agents.

COMPETITIVE INSIGHTS

There are major competing players for the hemostats and tissue sealants market from the North American region are Hyperbranch Medical Technology, Inc. (Acquired by Stryker), Medtronic PLC, Johnson & Johnson, B.Braun Melsungen AG, Advanced Medical Solutions (AMS) Group PLC, Baxter International Inc., Cohera Medical Inc., C.R. Bard, Inc., Cryolife Inc., CSL Behring, Integra Lifesciences Corp., Pfizer, Inc. and Smith & Nephew PLC.



目次

Table of Contents

1. RESEARCH SCOPE
1.1. STUDY GOALS
1.2. SCOPE OF THE MARKET STUDY
1.3. WHO WILL FIND THIS REPORT USEFUL?
1.4. STUDY AND FORECASTING YEARS
2. RESEARCH METHODOLOGY
2.1. SOURCES OF DATA
2.1.1. SECONDARY DATA
2.1.2. PRIMARY DATA
2.2. TOP DOWN APPROACH
2.3. BOTTOM-UP APPROACH
2.4. DATA TRIANGULATION
3. EXECUTIVE SUMMARY
3.1. MARKET SUMMARY
3.2. KEY FINDINGS
3.2.1. TOPICAL HEMOSTAT HOLDS THE LARGEST MARKET SHARE AND IS ANTICIPATED TO GROW AT A FASTER RATE DURING THE FORECAST PERIOD
3.2.2. SYNTHETIC TISSUE SEALANTS OF THE ADHESIVE AND TISSUE SEALANTS HOLDS THE LARGEST MARKET SHARE
4. MARKET DYNAMICS
4.1. MARKET SCOPE & DEFINITION
4.1.1. INCREASING INCIDENCE OF CHRONIC DISEASES
4.1.2. INCREASE IN AGING POPULATION
4.1.3. INCREASE IN NUMBER OF SURGERIES
4.2. MARKET RESTRAINTS
4.2.1. STRINGENT REGULATIONS
4.2.2. ADVERSE REACTIONS AND COMPLICATIONS
4.3. MARKET OPPORTUNITIES
4.3.1. USAGE OF HEMOSTASIS DEVICES AND TISSUE SEALANTS IN MULTIPLE CONDITIONS
4.3.2. ACCESSIBILITY OF MORE TREATMENT OPTIONS FOR MEDICAL PROFESSIONALS
4.4. MARKET CHALLENGES
4.4.1. LIMITATIONS ASSOCIATED WITH HEMOSTATS AND TISSUE SEALANTS
4.4.2. PRODUCT SIDE EFFECTS AND FDA SCRUTINY
5. MARKET BY PRODUCTS
5.1. TOPICAL HEMOSTAT
5.1.1. MECHANICAL HEMOSTATS
5.1.2. ACTIVE HEMOSTATS
5.1.3. FLOWABLE HEMOSTATS
5.2. ADHESIVE AND TISSUE SEALANTS
5.2.1. SYNTHETIC TISSUE SEALANT
5.2.1.1. OXIDIZED REGENERATED CELLULOSE
5.2.1.2. CYANOACRYLATE ADHESIVES
5.2.1.3. OTHER SYNTHETIC TISSUE SEALANTS
5.2.2. NATURAL TISSUE SEALANT
5.2.2.1. CHITIN AND CHITOSAN BASED HEMOSTATIC AGENT
5.2.2.2. OTHER NATURAL TISSUE SEALANT
5.2.3. ADHESION BARRIER PRODUCTS
6. KEY ANALYTICS
6.1. PORTER’S FIVE FORCE MODEL
6.1.1. THREAT OF NEW ENTRANTS
6.1.2. THREAT OF SUBSTITUTE
6.1.3. BARGAINING POWER OF SUPPLIERS
6.1.4. BARGAINING POWER OF BUYERS
6.1.5. THREAT OF COMPETITIVE RIVALRY
6.2. POLITICAL & LEGAL, ECONOMIC AND TECHNOLOGICAL SWOT ANALYSIS OF HEMOSTATS AND TISSUE SEALANTS MARKET
6.2.1. POLITICAL & LEGAL
6.2.2. ECONOMIC
6.2.3. TECHNOLOGICAL
6.3. MARKET TRENDS
6.4. OPPORTUNITY MATRIX
7. GEOGRAPHICAL ANALYSIS
7.1. NORTH AMERICA
7.1.1. THE UNITED STATES
7.1.2. CANADA
8. COMPETITIVE LANDSCAPE
8.1. MARKET POSITION ANALYSIS
8.2. COMPANY PROFILES
8.2.1. ADVANCED MEDICAL SOLUTIONS (AMS) GROUP PLC
8.2.1.1. COMPANY OVERVIEW
8.2.1.2. PRODUCT PORTFOLIO
8.2.1.3. STRATEGIC INITIATIVES
8.2.2. BAXTER INTERNATIONAL INC.
8.2.2.1. COMPANY OVERVIEW
8.2.2.2. PRODUCT PORTFOLIO
8.2.2.3. SCOT ANALYSIS
8.2.2.4. STRATEGIC INITIATIVES
8.2.3. B.BRAUN MELSUNGEN AG
8.2.3.1. OVERVIEW
8.2.3.2. PRODUCT PORTFOLIO
8.2.3.3. SCOT ANALYSIS
8.2.3.4. STRATEGIC ANALYSIS
8.2.4. COHERA MEDICAL INC.
8.2.4.1. COMPANY OVERVIEW
8.2.4.2. PRODUCT PORTFOLIO
8.2.4.3. STRATEGIC INITIATIVES
8.2.5. C. R. BARD, INC.
8.2.5.1. COMPANY OVERVIEW
8.2.5.2. PRODUCT PORTFOLIO
8.2.5.3. SCOT ANALYSIS
8.2.5.4. STRATEGIC INITIATIVES
8.2.6. CRYOLIFE INC.
8.2.6.1. COMPANY OVERVIEW
8.2.6.2. PRODUCT PORTFOLIO
8.2.6.3. STRATEGIC INITIATIVES
8.2.7. CSL BEHRING
8.2.7.1. COMPANY OVERVIEW
8.2.7.2. PRODUCT PORTFOLIO
8.2.7.3. STRATEGIC INITIATIVES
8.2.8. HYPERBRANCH MEDICAL TECHNOLOGY, INC. (ACQUIRED BY STRYKER)
8.2.8.1. COMPANY OVERVIEW
8.2.8.2. PRODUCT PORTFOLIO
8.2.8.3. STRATEGIC INITIATIVES
8.2.9. INTEGRA LIFESCIENCES CORP
8.2.9.1. COMPANY OVERVIEW
8.2.9.2. PRODUCT PORTFOLIO
8.2.9.3. SCOT ANALYSIS
8.2.9.4. STRATEGIC INITIATIVES
8.2.10. JOHNSON AND JOHNSON
8.2.10.1. COMPANY OVERVIEW
8.2.10.2. PRODUCT PORTFOLIO
8.2.10.3. SCOT ANALYSIS
8.2.10.4. STRATEGIC INITIATIVES
8.2.11. MEDTRONIC PLC
8.2.11.1. COMPANY OVERVIEW
8.2.11.2. PRODUCT PORTFOLIO
8.2.11.3. SCOT ANALYSIS
8.2.11.4. STRATEGIC INITIATIVES
8.2.12. PFIZER, INC.
8.2.12.1. COMPANY PROFILES
8.2.12.2. PRODUCT PORTFOLIO
8.2.12.3. SCOT ANALYSIS
8.2.12.4. STRATEGIC INITIATIVES
8.2.13. SMITH AND NEPHEW PLC
8.2.13.1. MARKET OVERVIEW
8.2.13.2. PRODUCT PORTFOLIO
8.2.13.3. SCOT ANALYSIS
8.2.13.4. STRATEGIC INITIATIVE
8.2.14. ZIMMER BIOMET HOLDINGS INC
8.2.14.1. MARKET OVERVIEW
8.2.14.2. PRODUCT PORTFOLIO
8.2.14.3. SCOT ANALYSIS
8.2.14.4. STRATEGIC INITIATIVES


TABLE LIST
TABLE 1 NORTH AMERICA HEMOSTATS AND TISSUE SEALANTS MARKET 2019-2027 ($ MILLION)
TABLE 2 NORTH AMERICA HEMOSTATS AND TISSUE SEALANTS MARKET BY PRODUCTS 2019-2027 ($ MILLION)
TABLE 3 NORTH AMERICA TOPICAL HEMOSTAT MARKET BY TYPES 2019-2027 ($ MILLION)
TABLE 4 NORTH AMERICA TOPICAL HEMOSTAT MARKET 2019-2027 ($ MILLION)
TABLE 5 NORTH AMERICA MECHANICAL HEMOSTATS MARKET 2019-2027 ($ MILLION)
TABLE 6 NORTH AMERICA ACTIVE HEMOSTATS MARKET 2019-2027 ($ MILLION)
TABLE 7 NORTH AMERICA FLOWABLE HEMOSTATS MARKET 2019-2027 ($ MILLION)
TABLE 8 NORTH AMERICA ADHESIVE AND TISSUE SEALANTS MARKET BY TYPES 2019-2027 ($ MILLION)
TABLE 9 NORTH AMERICA ADHESIVE AND TISSUE SEALANTS MARKET 2019-2027 ($ MILLION)
TABLE 10 NORTH AMERICA SYNTHETIC TISSUE SEALANT MARKET 2019-2027 ($ MILLION)
TABLE 11 NORTH AMERICA SYNTHETIC TISSUE SEALANT MARKET BY TYPES 2019-2027 ($ MILLION)
TABLE 12 NORTH AMERICA OXIDIZED REGENERATED CELLULOSE MARKET 2019-2027 ($ MILLION)
TABLE 13 NORTH AMERICA CYANOACRYLATE ADHESIVES MARKET 2019-2027 ($ MILLION)
TABLE 14 NORTH AMERICA OTHER SYNTHETIC TISSUE SEALANTS MARKET 2019-2027 ($ MILLION)
TABLE 15 NORTH AMERICA NATURAL TISSUE SEALANT MARKET 2019-2027 ($ MILLION)
TABLE 16 NORTH AMERICA NATURAL TISSUE SEALANT MARKET BY TYPES 2019-2027 ($ MILLION)
TABLE 17 NORTH AMERICA CHITIN AND CHITOSAN BASED HEMOSTATIC AGENT MARKET 2019-2027 ($ MILLION)
TABLE 18 NORTH AMERICA OTHER NATURAL TISSUE SEALANT MARKET 2019-2027 ($ MILLION)
TABLE 19 NORTH AMERICA ADHESION BARRIER PRODUCTS MARKET BY REAGENTS 2019-2027 ($ MILLION)
TABLE 20 NORTH AMERICA HEMOSTATS AND TISSUE SEALANTS MARKET BY COUNTRY 2019-2027 ($ MILLION)
TABLE 21 HEMOSTATS COMPANY MARKET POSITION ANALYSIS 2017 (%)
TABLE 22 TISSUE SEALANTS COMPANY MARKET POSITION ANALYSIS 2017 (%)
LIST OF FIGURES
FIGURE 1 PROCESS OF COAGULATION
FIGURE 2 NORTH AMERICA HEMOSTATS AND TISSUE SEALANTS MARKET 2018-2026 ($ MILLION)
FIGURE 3 NORTH AMERICA HEMOSTATS AND TISSUE SEALANTS MARKET SHARE BY PRODUCTS 2018 & 2027 (%)
FIGURE 4 NORTH AMERICA HEMOSTATS AND TISSUE SEALANTS MARKET BY TOPICAL HEMOSTAT 2019-2027 ($ MILLION)
FIGURE 5 NORTH AMERICA TOPICAL HEMOSTAT MARKET BY MECHANICAL HEMOSTATS 2019-2027 ($ MILLION)
FIGURE 6 NORTH AMERICA TOPICAL HEMOSTAT MARKET BY ACTIVE HEMOSTATS 2019-2027 ($ MILLION)
FIGURE 7 NORTH AMERICA TOPICAL HEMOSTAT MARKET BY FLOWABLE HEMOSTATS 2019-2027 ($ MILLION)
FIGURE 8 NORTH AMERICA HEMOSTATS AND TISSUE SEALANTS MARKET BY ADHESIVE AND TISSUE SEALANTS 2019-2027 ($ MILLION)
FIGURE 9 NORTH AMERICA ADHESIVE AND TISSUE SEALANTS MARKET BY SYNTHETIC TISSUE SEALANT 2019-2027 ($ MILLION)
FIGURE 10 NORTH AMERICA SYNTHETIC TISSUE SEALANT MARKET BY OXIDIZED REGENERATED CELLULOSE 2019-2027 ($ MILLION)
FIGURE 11 NORTH AMERICA SYNTHETIC TISSUE SEALANT MARKET BY CYANOACRYLATE ADHESIVES 2019-2027 ($ MILLION)
FIGURE 12 NORTH AMERICA SYNTHETIC TISSUE SEALANT MARKET BY OTHER SYNTHETIC TISSUE SEALANTS 2019-2027 ($ MILLION)
FIGURE 13 NORTH AMERICA ADHESIVE AND TISSUE SEALANTS MARKET BY NATURAL TISSUE SEALANT 2019-2027 ($ MILLION)
FIGURE 14 NORTH AMERICA NATURAL TISSUE SEALANT MARKET BY CHITIN AND CHITOSAN BASED HEMOSTATIC AGENT 2019-2027 ($ MILLION)
FIGURE 15 NORTH AMERICA NATURAL TISSUE SEALANT MARKET BY CHITIN AND OTHER NATURAL TISSUE SEALANT 2019-2027 ($ MILLION)
FIGURE 16 NORTH AMERICA ADHESIVE AND TISSUE SEALANTS MARKET BY ADHESION BARRIER PRODUCTS 2019-2027 ($ MILLION)
FIGURE 17 PORTER’S FIVE FORCE MODEL
FIGURE 18 NORTH AMERICA HEMOSTATS AND TISSUE SEALANTS MARKET REGIONAL OUTLOOK 2018 & 2027 (%)
FIGURE 19 THE UNITED STATES HEMOSTATS AND TISSUE SEALANTS MARKET 2019-2027 ($ MILLION)
FIGURE 20 CANADA HEMOSTATS AND TISSUE SEALANTS MARKET 2019-2027 ($ MILLION)
FIGURE 21 THE UNITED KINGDOM HEMOSTATS AND TISSUE SEALANTS MARKET 2019-2027 ($ MILLION)

List of Tables

TABLE LIST
TABLE 1 NORTH AMERICA HEMOSTATS AND TISSUE SEALANTS MARKET 2019-2027 ($ MILLION)
TABLE 2 NORTH AMERICA HEMOSTATS AND TISSUE SEALANTS MARKET BY PRODUCTS 2019-2027 ($ MILLION)
TABLE 3 NORTH AMERICA TOPICAL HEMOSTAT MARKET BY TYPES 2019-2027 ($ MILLION)
TABLE 4 NORTH AMERICA TOPICAL HEMOSTAT MARKET 2019-2027 ($ MILLION)
TABLE 5 NORTH AMERICA MECHANICAL HEMOSTATS MARKET 2019-2027 ($ MILLION)
TABLE 6 NORTH AMERICA ACTIVE HEMOSTATS MARKET 2019-2027 ($ MILLION)
TABLE 7 NORTH AMERICA FLOWABLE HEMOSTATS MARKET 2019-2027 ($ MILLION)
TABLE 8 NORTH AMERICA ADHESIVE AND TISSUE SEALANTS MARKET BY TYPES 2019-2027 ($ MILLION)
TABLE 9 NORTH AMERICA ADHESIVE AND TISSUE SEALANTS MARKET 2019-2027 ($ MILLION)
TABLE 10 NORTH AMERICA SYNTHETIC TISSUE SEALANT MARKET 2019-2027 ($ MILLION)
TABLE 11 NORTH AMERICA SYNTHETIC TISSUE SEALANT MARKET BY TYPES 2019-2027 ($ MILLION)
TABLE 12 NORTH AMERICA OXIDIZED REGENERATED CELLULOSE MARKET 2019-2027 ($ MILLION)
TABLE 13 NORTH AMERICA CYANOACRYLATE ADHESIVES MARKET 2019-2027 ($ MILLION)
TABLE 14 NORTH AMERICA OTHER SYNTHETIC TISSUE SEALANTS MARKET 2019-2027 ($ MILLION)
TABLE 15 NORTH AMERICA NATURAL TISSUE SEALANT MARKET 2019-2027 ($ MILLION)
TABLE 16 NORTH AMERICA NATURAL TISSUE SEALANT MARKET BY TYPES 2019-2027 ($ MILLION)
TABLE 17 NORTH AMERICA CHITIN AND CHITOSAN BASED HEMOSTATIC AGENT MARKET 2019-2027 ($ MILLION)
TABLE 18 NORTH AMERICA OTHER NATURAL TISSUE SEALANT MARKET 2019-2027 ($ MILLION)
TABLE 19 NORTH AMERICA ADHESION BARRIER PRODUCTS MARKET BY REAGENTS 2019-2027 ($ MILLION)
TABLE 20 NORTH AMERICA HEMOSTATS AND TISSUE SEALANTS MARKET BY COUNTRY 2019-2027 ($ MILLION)
TABLE 21 HEMOSTATS COMPANY MARKET POSITION ANALYSIS 2017 (%)
TABLE 22 TISSUE SEALANTS COMPANY MARKET POSITION ANALYSIS 2017 (%)

List of Figures

LIST OF FIGURES
FIGURE 1 PROCESS OF COAGULATION
FIGURE 2 NORTH AMERICA HEMOSTATS AND TISSUE SEALANTS MARKET 2018-2026 ($ MILLION)
FIGURE 3 NORTH AMERICA HEMOSTATS AND TISSUE SEALANTS MARKET SHARE BY PRODUCTS 2018 & 2027 (%)
FIGURE 4 NORTH AMERICA HEMOSTATS AND TISSUE SEALANTS MARKET BY TOPICAL HEMOSTAT 2019-2027 ($ MILLION)
FIGURE 5 NORTH AMERICA TOPICAL HEMOSTAT MARKET BY MECHANICAL HEMOSTATS 2019-2027 ($ MILLION)
FIGURE 6 NORTH AMERICA TOPICAL HEMOSTAT MARKET BY ACTIVE HEMOSTATS 2019-2027 ($ MILLION)
FIGURE 7 NORTH AMERICA TOPICAL HEMOSTAT MARKET BY FLOWABLE HEMOSTATS 2019-2027 ($ MILLION)
FIGURE 8 NORTH AMERICA HEMOSTATS AND TISSUE SEALANTS MARKET BY ADHESIVE AND TISSUE SEALANTS 2019-2027 ($ MILLION)
FIGURE 9 NORTH AMERICA ADHESIVE AND TISSUE SEALANTS MARKET BY SYNTHETIC TISSUE SEALANT 2019-2027 ($ MILLION)
FIGURE 10 NORTH AMERICA SYNTHETIC TISSUE SEALANT MARKET BY OXIDIZED REGENERATED CELLULOSE 2019-2027 ($ MILLION)
FIGURE 11 NORTH AMERICA SYNTHETIC TISSUE SEALANT MARKET BY CYANOACRYLATE ADHESIVES 2019-2027 ($ MILLION)
FIGURE 12 NORTH AMERICA SYNTHETIC TISSUE SEALANT MARKET BY OTHER SYNTHETIC TISSUE SEALANTS 2019-2027 ($ MILLION)
FIGURE 13 NORTH AMERICA ADHESIVE AND TISSUE SEALANTS MARKET BY NATURAL TISSUE SEALANT 2019-2027 ($ MILLION)
FIGURE 14 NORTH AMERICA NATURAL TISSUE SEALANT MARKET BY CHITIN AND CHITOSAN BASED HEMOSTATIC AGENT 2019-2027 ($ MILLION)
FIGURE 15 NORTH AMERICA NATURAL TISSUE SEALANT MARKET BY CHITIN AND OTHER NATURAL TISSUE SEALANT 2019-2027 ($ MILLION)
FIGURE 16 NORTH AMERICA ADHESIVE AND TISSUE SEALANTS MARKET BY ADHESION BARRIER PRODUCTS 2019-2027 ($ MILLION)
FIGURE 17 PORTER’S FIVE FORCE MODEL
FIGURE 18 NORTH AMERICA HEMOSTATS AND TISSUE SEALANTS MARKET REGIONAL OUTLOOK 2018 & 2027 (%)
FIGURE 19 THE UNITED STATES HEMOSTATS AND TISSUE SEALANTS MARKET 2019-2027 ($ MILLION)
FIGURE 20 CANADA HEMOSTATS AND TISSUE SEALANTS MARKET 2019-2027 ($ MILLION)
FIGURE 21 THE UNITED KINGDOM HEMOSTATS AND TISSUE SEALANTS MARKET 2019-2027 ($ MILLION)

 

COPYRIGHT(C) 2011-2019 DATA RESOURCES, Inc. ALL RIGHTS RESERVED.